ScreenerHero
ALCAlcon AG
SWX · CH · Healthcare · Medical Instruments & Supplies · alcon.com
58.14CHF-1.92%Mkt Cap: 32.71B $P/E: 55.92

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics…

Industry Peers

Medical Instruments & Supplies
Screen all
ISRG
Intuitive Surgical, Inc.
$142.49BUSDP/E 45.6
EL
EssilorLuxottica Societe anonyme
$80.53BUSDP/E 30.2
BDX
Becton, Dickinson and Company
$51.10BUSDP/E 32.5
MDLN
Medline Inc. Class A Common Stock
$45.62BUSDP/E 42.4
RMD
ResMed Inc.
$33.27BUSDP/E 22.1
WST
West Pharmaceutical Services, Inc.
$24.90BUSDP/E 45.4
DIM
Sartorius Stedim Biotech
$20.62BUSDP/E 64.6
SRT3
Sartorius Aktiengesellschaft
$18.68BUSDP/E 87.6
STMN
Straumann Holding AG
$17.47BUSDP/E 41.6
SRT
Sartorius Aktiengesellschaft
$15.01BUSDP/E 70.4
COLO-B
Coloplast A/S
$14.31BUSDP/E 35.6
SOLV
Solventum Corporation
$15.08BUSDP/E 10.8
COO
The Cooper Companies, Inc.
$14.85BUSDP/E 64.5
BAX
Baxter International Inc.
$13.77BUSD
ALGN
Align Technology, Inc.
$11.58BUSDP/E 28.3
RGEN
Repligen Corporation
$9.95BUSDP/E 241.6
AVTR
Avantor, Inc.
$9.44BUSD
ATR
AptarGroup, Inc.
$8.45BUSDP/E 24.0
YPSN
Ypsomed Holding AG
$6.15BUSDP/E 25.1
STVN
Stevanato Group S.p.A.
$6.10BUSDP/E 39.2

Key Statistics

Company
Market Cap32.71B $
Enterprise Value37.09B $
Revenue (TTM)12.40B $
Gross Profit6.56B $
Net Income (TTM)1.12B $
Revenue/Share25.35 USD
Last Price58.14 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees25.0K
CountryCH
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINCH0432492467
Valuation
P/E (Trailing)55.92
P/E (Forward)16.73
PEG1.51
EV/EBITDA13.52
EV/Revenue2.99
P/S2.60
P/B1.61
EPS (TTM)1.06
EPS (Forward)3.49
52W Range
47.8041% of range72.88
52W High72.88 CHF
52W Low47.80 CHF
Profitability
Gross Margin55.24%
Oper. Margin14.63%
EBITDA Margin22.13%
Profit Margin9.42%
ROE4.45%
ROA3.11%
Growth
Revenue Growth8.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.59B $
CapEx (TTM)756.68M $
FCF Margin11.72%
FCF Yield4.44%
Net Debt4.38B $
Net Debt/EBITDA1.60
Balance Sheet
Debt/Equity0.02
Current Ratio2.09
Quick Ratio1.12
Book Value/Sh36.29 CHF
Cash/Share3.014 CHF
Dividends
Fwd Div Rate0.2800 CHF
Trail. Div Rate0.3530 CHF
Div. Yield0.47%
5Y Avg Yield0.31%
Payout Ratio27.03%
Ex-Div DateMay 5, 2026
Pay DateMay 15, 2025
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)72.97 CHF
Upside (mean)+25.5%
Target Range47.31 CHF – 83.88 CHF
CHF47.31+25.5% to meanCHF83.88
# Analysts17
Ownership
Shares Out.483.40M
Float481.83M
Insiders0.20%
Institutions66.10%
Technical
SMA 5055.70 (+4.4%)
SMA 20059.20 (-1.8%)
Beta0.69
S&P 52W Chg18.16%
Avg Vol (30d)1.32M
Avg Vol (10d)1.53M
Technical Indicators
RSI (14)58.6
MACD1.2592
MACD Signal1.0737
MACD Hist.+0.1855
BB Upper61.34 CHF
BB Middle57.46 CHF
BB Lower53.58 CHF
BB Width13.51%
ATR (14)1.505 CHF
Vol Ratio (20d)0.54x